HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by ’t Hart, L. M. Articles by van Haeften, T. W. Search for Related Content PubMed PubMed Citation Articles by ’t Hart, L. M. Articles by van Haeften, T. W. Social Bookmarking                What's this?

Variations in Insulin Secretion in Carriers of Gene Variants in IRS-1 and -2

¹ Department of Molecular Cell Biology, Leiden University Medical Center, Leiden, the Netherlands
² Institute for Research in Extramural Medicine (EMGO), Vrije Universiteit Amsterdam, Amsterdam, the Netherlands
³ Department of Internal Medicine, University Medical Center, Utrecht, the Netherlands

Associations between type 2 diabetes (and/or parameters contributing to glucose homeostasis) and genetic variation in the genes encoding insulin receptor substrate (IRS)-1 and -2 have been reported in several populations. Recently, it has been reported that the Gly⁹⁷²Arg variant in IRS-1 was associated with reduced insulin secretion during hyperglycemic clamps in German subjects with normal glucose tolerance. We have examined glucose-stimulated insulin secretion in relation to gene variants in the IRS-1 (Gly⁹⁷²Arg) and IRS-2 (Gly¹⁰⁵⁷Asp) genes in two Dutch cohorts. Subjects with normal (n = 64) or impaired (n = 94) glucose tolerance underwent 3-h hyperglycemic clamps at 10 mmol/l glucose. All subjects were genotyped for the IRS-1 and IRS-2 variants by PCR-RFLP–based methods. We did not observe any significant difference in both first- and second-phase insulin secretion between carriers and noncarriers of both gene variants, nor was there evidence for an association with other diabetes-related parameters. We conclude that the common gene variants in IRS-1 and IRS-2 are not associated with altered glucose-stimulated insulin secretion in two populations from the Netherlands.

CiteULike

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				O. Tschritter, A. Fritsche, F. Shirkavand, F. Machicao, H. Haring, and M. Stumvoll Assessing the Shape of the Glucose Curve During an Oral Glucose Tolerance Test Diabetes Care, April 1, 2003; 26(4): 1026 - 1033. [Abstract] [Full Text] [PDF]

				R. D'Alfonso, M. A. Marini, L. Frittitta, R. Sorge, S. Frontoni, O. Porzio, L. M. Mariani, D. Lauro, S. Gambardella, V. Trischitta, et al. Polymorphisms of the Insulin Receptor Subtrate-2 in Patients with Type 2 Diabetes J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 317 - 322. [Abstract] [Full Text] [PDF]

				L. M. 't Hart, T. W. van Haeften, J. M. Dekker, M. Bot, R. J. Heine, and J. A. Maassen Variations in Insulin Secretion in Carriers of the E23K Variant in the KIR6.2 Subunit of the ATP-Sensitive K+ Channel in the {beta}-Cell Diabetes, October 1, 2002; 51(10): 3135 - 3138. [Abstract] [Full Text] [PDF]